Text Size

Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Department of Veterans Affairs
ClinicalTrials.gov Identifier:
NCT00439816
First received: February 22, 2007
Last updated: January 24, 2013
Last verified: November 2007
History of Changes
  Purpose

To determine racial/ethnic differences in preference for group visits in veterans with poorly controlled hypertension (State 2 hypertension) and determine the effect of group visits on health outcomes among veterans with poorly controlled hypertension.


Condition Intervention
Hypertension
Blood Pressure
 Behavioral: Group Visits

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Veteran Preference For Group Visits and Its Effect on Hypertension Outcomes

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Department of Veterans Affairs:

Primary Outcome Measures:
  • Blood pressure control. Medication compliance (as measured by refill histories). Health services utilization patterns (as defined by days in hospital, outpatient visits and urgent care visits). [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Acceptability of group visits to White and African American veterans, measured by comparing proportion of those who agreed to participate in groups to those who didn't. The attendance rates by patient race/ethnicity among those assigned to group visits. [ Designated as safety issue: No ]

Enrollment: 160
Study Start Date: February 2005
Study Completion Date: September 2007
Arms Assigned Interventions
Arm 1 Behavioral: Group Visits

  Show Detailed Description

  Eligibility

Ages Eligible for Study:   21 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

Caucasian and African American men and women, age 21 and older with stage 2 hypertension presently seen in the RHJ VAMC Primary Care.

Exclusion Criteria:

Primary diagnosis of substance abuse or dependence, current pregnancy, dementia, inability to speak English, or controlled psychiatric diagnoses.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00439816

Locations
United States, South Carolina
Ralph H Johnson VA Medical Center, Charleston
Charleston, South Carolina, United States, 29401-5799
Sponsors and Collaborators
Department of Veterans Affairs
Investigators
Principal Investigator: Dawn E Clancy, MD Adult Primary Care Center
  More Information

Publications:

Responsible Party: Department of Veterans Affairs
ClinicalTrials.gov Identifier: NCT00439816     History of Changes
Other Study ID Numbers: LIP 82-003, HR 11260
Study First Received: February 22, 2007
Last Updated: January 24, 2013
Health Authority: United States: Federal Government

Keywords provided by Department of Veterans Affairs:
Hypertension Outcomes
Health Outcomes
Outpatient
Racial Preference
Blood Pressure Control
 Clinical Trial
Intervention
Lifestyle modifications
Ethnic Differences
Randomized

Additional relevant MeSH terms:
Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on May 23, 2013